Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · Real-Time Price · USD
1.090
+0.010 (0.93%)
Sep 4, 2026, 4:00 PM EDT - Market closed
Cardiff Oncology Market Cap
Cardiff Oncology has a market cap or net worth of $84.8 million as of September 4, 2026. Its market cap has decreased by -34.97% in one year.
Market Cap
84.80M
Enterprise Value
50.73M
1-Year Change
-34.97%
Ranking
Category
Stock Price
$1.09
ChartMarket Cap Chart
Since May 29, 2012, Cardiff Oncology's market cap has increased from $56.00M to $84.80M, an increase of 51.42%. That is a compound annual growth rate of 2.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 84.80M | -55.20% |
| Dec 31, 2025 | 189.30M | -14.69% |
| Dec 31, 2024 | 221.90M | 235.70% |
| Dec 29, 2023 | 66.10M | 5.76% |
| Dec 30, 2022 | 62.50M | -73.71% |
| Dec 31, 2021 | 237.70M | -62.60% |
| Dec 31, 2020 | 635.50M | 6,519.79% |
| Dec 31, 2019 | 9.60M | -20.66% |
| Dec 31, 2018 | 12.10M | 3.42% |
| Dec 29, 2017 | 11.70M | -81.80% |
| Dec 30, 2016 | 64.30M | -59.94% |
| Dec 31, 2015 | 160.50M | 97.42% |
| Dec 31, 2014 | 81.30M | -25.07% |
| Dec 31, 2013 | 108.50M | 10.38% |
| Dec 31, 2012 | 98.30M | 75.54% |
| May 29, 2012 | 56.00M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ImmuCell | 89.91M |
| Rallybio | 89.88M |
| Aldeyra Therapeutics | 89.28M |
| OS Therapies | 86.72M |
| Gossamer Bio | 85.69M |
| Yarrow Bioscience | 84.59M |
| iBio, Inc. | 84.24M |
| OKYO Pharma | 82.39M |